UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

Annals of oncology, 2015-04, Vol.26 (4), p.798-803

2015

Volltextzugriff (PDF)

Preliminary data for assessing the impact of psychological stress on the development of primitive tumors or relapses of disease

Annals of oncology, 2017-10, Vol.28, p.vi87-vi87

2017

Volltextzugriff (PDF)

The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience

Supportive care in cancer, 2016-10, Vol.24 (10), p.4293-4299

2016

Volltextzugriff (PDF)

Metastatic melanoma patients treated with Braf and Mek inhibitors: Patterns of progression. An Italian Melanoma Intergroup study

Annals of oncology, 2017-10, Vol.28, p.vi68-vi69

2017

Volltextzugriff (PDF)

CREAM study: Clinical correlation between immunotherapy-RElated colitis And intestinal Microbiote in metastatic patients

Annals of oncology, 2017-10, Vol.28, p.vi100-vi101

2017

Volltextzugriff (PDF)

PP101-MON AN EFFECTIVE AND SAFE TWO-DRUG COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA

Clinical nutrition (Edinburgh, Scotland), 2013-09, Vol.32, p.S160-S160

2013

Volltextzugriff (PDF)

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

OncoTargets and therapy, 2015-01, Vol.8 (default), p.157-168

2015

Volltextzugriff (PDF)

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

European journal of immunology, 2016-02, Vol.46 (2), p.409-419

2016

Volltextzugriff (PDF)

Patterns of progression in metastatic melanoma patients treated with Braf and Mek inhibitors: an Italian Melanoma Intergroup (IMI) study

Annals of oncology, 2017-09, Vol.28, p.v442-v443

2017

Volltextzugriff (PDF)

51TiP A new way to fight early recurrences: we need it, we'll find it

Annals of oncology, 2015-12, Vol.26, p.ix8-ix8

2015

Volltextzugriff (PDF)

403TiP CREAM study: Clinical correlation between ipilimumab- Related colitis And intestinal Microbiote in metastatic melanoma patients

Annals of oncology, 2016-12, Vol.27, p.ix125-ix125

2016

Volltextzugriff (PDF)

403TiP CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

The liquid biopsy as a new ally to fight cancer?

Annals of oncology, 2015-10, Vol.26, p.vi151

2015

Volltextzugriff (PDF)

REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol)

Annals of oncology, 2016-10, Vol.27, p.vi204-vi204

2016

Volltextzugriff (PDF)

Selection with a molecUlar PanEl foR Panitumumab EfficAcy in K-ras and n-ras wild type metastatic colorectal cancer (SUPER- PEAK)

Annals of oncology, 2016-10, Vol.27, p.vi205-vi205

2016

Volltextzugriff (PDF)

Selection with a molecUlar PanEl foR Panitumumab EfficAcy in K-ras and n-ras wild type metastatic colorectal cancer (SUPER- PEAK)

Annals of oncology, 2016-09, Vol.27, p.iv52

2016

Volltextzugriff (PDF)

REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol)

Annals of oncology, 2016-09, Vol.27, p.iv53

2016

Volltextzugriff (PDF)

409P CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients

Annals of oncology, 2016-12, Vol.27, p.ix127-ix127

2016

Volltextzugriff (PDF)

409P CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

1604P - Case-Control Phase II Clinical Trial to Assess Efficacy and Safety, of the Same Antineoplastic Treatment(S) in Elderly “Fit” Compared to Adult Patients with Cancer at Different Sites

Annals of oncology, 2012-09, Vol.23, p.ix516-ix517

2012

Volltextzugriff (PDF)

Case-Control Phase II Clinical Trial to Assess Efficacy and Safety, of the Same Antineoplastic Treatment(S) in Elderly “Fit” Compared to Adult Patients with Cancer at Different Sites

Annals of oncology, 2012-09, Vol.23, p.ix516-ix517

2012

Volltextzugriff (PDF)

CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients

Annals of oncology, 2016-10, Vol.27, p.vi386-vi386

2016

Volltextzugriff (PDF)

CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients

Annals of oncology, 2016-09, Vol.27, p.iv89

2016

Volltextzugriff (PDF)

476P - Trastuzumab-Induced Early Cardiac Dysfunction Assessed by Speckle Tracking Echocardiography: Correlation with Chronic Inflammation and Oxidative Stress Markers

Annals of oncology, 2012-09, Vol.23, p.ix164-ix164

2012

Volltextzugriff (PDF)

Trastuzumab-Induced Early Cardiac Dysfunction Assessed by Speckle Tracking Echocardiography: Correlation with Chronic Inflammation and Oxidative Stress Markers

Annals of oncology, 2012-09, Vol.23, p.ix164

2012

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(4)
Science & Technology
(4)
Humans
(3)
Oncology
(3)
Adult
(2)
Aged
(2)
Cancer
(2)
Care And Treatment
(2)
Drug Resistance
(2)
Female
(2)
Immunotherapy
(2)
Male
(2)
Melanoma
(2)
Middle Aged
(2)
Acquired Drug Resistance
(1)
Aged, 80 And Over
(1)
Antibodies, Monoclonal - Administration & Dosage
(1)
Antigens
(1)
Antineoplastic Agents
(1)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

Preliminary data for assessing the impact of psychological stress on the development of primitive tumors or relapses of disease

The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience

Metastatic melanoma patients treated with Braf and Mek inhibitors: Patterns of progression. An Italian Melanoma Intergroup study

CREAM study: Clinical correlation between immunotherapy-RElated colitis And intestinal Microbiote in metastatic patients

PP101-MON AN EFFECTIVE AND SAFE TWO-DRUG COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

Patterns of progression in metastatic melanoma patients treated with Braf and Mek inhibitors: an Italian Melanoma Intergroup (IMI) study

51TiP A new way to fight early recurrences: we need it, we'll find it

403TiP CREAM study: Clinical correlation between ipilimumab- Related colitis And intestinal Microbiote in metastatic melanoma patients

403TiP CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients

The liquid biopsy as a new ally to fight cancer?

REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol)

Selection with a molecUlar PanEl foR Panitumumab EfficAcy in K-ras and n-ras wild type metastatic colorectal cancer (SUPER- PEAK)

Selection with a molecUlar PanEl foR Panitumumab EfficAcy in K-ras and n-ras wild type metastatic colorectal cancer (SUPER- PEAK)

REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol)

409P CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients

409P CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients

1604P - Case-Control Phase II Clinical Trial to Assess Efficacy and Safety, of the Same Antineoplastic Treatment(S) in Elderly “Fit” Compared to Adult Patients with Cancer at Different Sites

Case-Control Phase II Clinical Trial to Assess Efficacy and Safety, of the Same Antineoplastic Treatment(S) in Elderly “Fit” Compared to Adult Patients with Cancer at Different Sites

CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients

CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients

476P - Trastuzumab-Induced Early Cardiac Dysfunction Assessed by Speckle Tracking Echocardiography: Correlation with Chronic Inflammation and Oxidative Stress Markers

Trastuzumab-Induced Early Cardiac Dysfunction Assessed by Speckle Tracking Echocardiography: Correlation with Chronic Inflammation and Oxidative Stress Markers

Suchergebnisse filtern